Reviewed by Laurence P. Banville, Esq.Frequently asked questions
What is the antacid cancer lawsuit about?
The antacid cancer lawsuits primarily involve ranitidine (Zantac), which the FDA recalled in 2020 after finding it contained NDMA, a probable human carcinogen. Plaintiffs allege that manufacturers knew or should have known the drug degraded into dangerous levels of NDMA and failed to warn consumers. Cases involve claims of stomach cancer, bladder cancer, colorectal cancer, and other NDMA-linked cancers.
Who qualifies to file an antacid cancer lawsuit in New York?
New York residents who took ranitidine (Zantac) or other NDMA-contaminated antacids for a sustained period and were later diagnosed with a cancer linked to NDMA exposure may qualify to file a claim. Eligibility depends on the duration of use, dosage, cancer type, and the timing of your diagnosis relative to your antacid use. An attorney can evaluate whether your specific facts support a viable product liability claim.
What is the statute of limitations for an antacid cancer lawsuit in New York?
Under CPLR §214, New York generally imposes a 3-year statute of limitations for personal injury claims, including product liability cases. The clock typically starts when you knew or should have known your cancer was linked to antacid use. Because the discovery rule can be complex to apply, you should consult a NY attorney as soon as possible to protect your right to sue.
What damages can I recover in a NY antacid cancer lawsuit?
New York plaintiffs in antacid cancer cases may seek compensation for medical expenses, lost wages, pain and suffering, and reduced quality of life. Wrongful death claims are also available for families who lost a loved one to an NDMA-linked cancer. No outcome is guaranteed, and results depend on the specific facts of your case, so speaking with an experienced NY product liability attorney is the critical first step.